Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UW-Madison researchers identify key to cancer cell mobility

07.11.2002


In the race to cure cancer, researchers look for roadblocks that could stop cancer in its tracks, preventing it from spreading to other parts of the body. Scientists from the University of Wisconsin-Madison may have found that blockade - an enzyme critical to the ability of cells to metastasize, a biological phenomenon by which cells migrate. The findings are published in the Nov. 7 issue of the journal Nature.



"The real, life-threatening problem with most cancers is that they migrate away from the initial site," says Richard Anderson, a UW-Madison pharmacology professor and senior author of the paper. "If we could regulate a cell’s ability to move in a selective way, we may be able to block cancer metastasis."

Researchers have identified several important factors involved in cell migration, but they continue to search for the mechanisms that regulate these key factors. Anderson and his group have found that the enzyme, noted scientifically as PIPKI?661, appears to underpin cells’ ability to move from organ to organ.


Cells can migrate through the body because they have small clusters of proteins called focal adhesions. When these clusters, located on the cell surface, respond to signals from molecules on other cells, they bind to those molecules. Once attached, the focal adhesions can pull the cell forward. Like wheels on a skateboard, these adhesions then give cells the ability to move around the body.

The key to blocking this movement, says Anderson, is inhibiting the assembly of focal adhesions. But, as he adds, these protein clusters result from the activity of several key factors, which receive their signals from a number of sources - proteins inside the cell or molecules outside it. To block focal adhesion assembly, one would have to block this other activity.

The key to doing that appears to be the enzyme, PIPKI?661, identified by Anderson and his colleagues, Kun Ling and Renee Doughman.

"What we’ve identified is an enzyme that regulates the assembly of focal adhesions," says Anderson. "Researchers have been looking for this enzyme for years."

PIPKI?661 interacts directly with two key proteins (FAK and talin) involved in focal adhesion assembly. At the same time, PIPKI?661 also generates an important second messenger (P14,5P2) that Anderson says both regulates a number of important proteins inside the cell and stimulates their ability to form focal adhesions.

Because of this enzyme’s central role in regulating the factors involved in the assembly of focal adhesions, the researchers say it provides a promising target for developing drugs to prevent cancer cells from metastasizing.

"PIPKI?661 is like one of those circular (traffic) intersections in Italy and England," says Anderson. "There are all sorts of signals feeding in and out of it, and the traffic never stops." Changing the design of the intersection, he says, could change the flow of those signals.

By blocking the activity of PIPKI?661 - the intersection of focal adhesion assembly - cancer cells could become immobile, thereby unable to migrate to other parts of the body.

"Exactly how cancer cells metastasize has been poorly understood," says Anderson. "This discovery is a real breakthrough that could really have an impact."


- Emily Carlson, (608) 262-9772, emilycarlson@wisc.edu

Richard Anderson | EurekAlert!
Further information:
http://www.wisc.edu/

More articles from Health and Medicine:

nachricht Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

What the world's tiniest 'monster truck' reveals

23.08.2017 | Life Sciences

Treating arthritis with algae

23.08.2017 | Life Sciences

Witnessing turbulent motion in the atmosphere of a distant star

23.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>